Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway.
about
Role of Nrf2 in oxidative stress and toxicityAccelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null miceNrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagyp62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcriptionNeuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosisThe life cycle of the 26S proteasome: from birth, through regulation and function, and onto its deathRole of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyRedox control of microglial function: molecular mechanisms and functional significanceLoss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegenerationTranscription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cellsNuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in miceNuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung FibrosisWhen NRF2 talks, who's listening?Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A reviewAging and immune function: molecular mechanisms to interventionsBasic principles and emerging concepts in the redox control of transcription factorsRegulation of proteasome activity in health and diseaseCytoprotection "gone astray": Nrf2 and its role in cancerNrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cellsMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseNRF2-regulation in brain health and disease: implication of cerebral inflammationCharacterization of Nrf1b, a novel isoform of the nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genesModulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseasesHeightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity.Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.Genetic deletion of Nrf2 promotes immortalization and decreases life span of murine embryonic fibroblasts.Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice.Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts.Basic leucine zipper protein Cnc-C is a substrate and transcriptional regulator of the Drosophila 26S proteasome.PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation.The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solutionUbiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implicationsRegulation of notch1 signaling by nrf2: implications for tissue regenerationNRF2, cancer and calorie restrictionAltered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-ratSulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27.Regulating the 20S proteasome ubiquitin-independent degradation pathway.The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexesAlterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases
P2860
Q23919669-31842A2F-2010-4E73-8D6B-96D5B0AB988CQ23923904-4CA71124-291B-4E0B-A4D0-5EB2375AE0ADQ24296827-D35DED3F-6AC8-482C-B202-F4AE6C2A6747Q24310885-5DBA7453-DABD-4433-8A84-FDB2D0831498Q24623266-41B9B53B-D177-4BB7-8399-8A58B372DBCAQ26738549-47C34B0C-1DCF-4CD9-952E-77883C83BEADQ26751266-19219B0A-593A-4923-B137-510AA5301C93Q26801207-EFB31CCB-781D-4815-A36D-D89ADEDC0853Q27000279-E32C3DF0-A0B7-4E6E-B146-7EF16B87E5E7Q28236609-68D968D5-C0B2-44BA-8C53-C4F5CA34B528Q28279454-7EB4168E-D1B5-45DB-AB93-604017E860F4Q28291312-104701EF-DA2E-4970-A161-7FC50001516BQ28383171-00B18772-5632-4AFF-ACFB-53CD4B5FD8BDQ28384223-603389E5-A5F5-4C6B-87F5-A3C6854C98E3Q28386665-2AE49375-A9F4-4263-B601-396648569A43Q28387056-8581C177-CBC1-48B7-8168-68DA71624A76Q28391506-F5DE6605-135F-456A-99FA-4176B956E852Q28392708-7FD7F077-E209-4ACB-A68A-81BAFDE68F5DQ28393784-70AC2706-151A-4256-AF05-00101A1601BCQ28394410-D1372DF7-A799-49C9-A780-5AD037C5ED81Q28394732-D0986F71-F0D4-4C89-82A4-2F1F62D41AFCQ28397785-CA7B0A4A-217B-47C0-911C-86A6E7FE9232Q28587680-EC9B2F9E-4770-4D20-A432-0FD5C5546EEAQ29247921-C0A34946-6A91-4347-9996-E340C636BED4Q33551463-41ADB88B-0F4C-48E0-8A5E-4357035137C7Q33556178-28FE061A-86D1-4261-A9C8-48E6136F1934Q33557928-E33388D3-B660-400B-99EC-62043D582A88Q33614059-4FCB9A3D-8E30-4E4B-9F00-77D37140BB07Q33707090-48317CEF-B217-4BD4-9CE6-2359EB844570Q33768364-975B6EED-3EA4-4B13-9B74-841B62121A24Q33878865-27B6794D-0C47-40BB-8E62-89A7D96DF5E1Q33980214-444DAEAE-FC18-4E40-9403-2AA4085D7619Q34012297-76567645-38A1-4B99-8012-0E8707B5032DQ34101123-5F473340-317C-482A-B600-F22C9F03F52BQ34148599-37004612-07D0-42F2-B639-E013F99A22B8Q34261611-F2692AD7-68F8-46C5-A09D-032BFD60F033Q34285116-EA00B6A2-4EAB-46AC-8E41-3A4BAEF98193Q34318192-7C69123F-B862-431A-99C5-F102244B1DAEQ34328313-F6934D76-DD3C-4C2A-9F26-D5413FC1E859Q34427577-11FE1A43-D7BB-49A2-ADF4-56B6A15DE05C
P2860
Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@en
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@nl
type
label
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@en
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@nl
prefLabel
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@en
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@nl
P2093
P2860
P1476
Antioxidants enhance mammalian ...... Keap1-Nrf2 signaling pathway.
@en
P2093
Jennifer L Greenlaw
Masayuki Yamamoto
Mi-Kyoung Kwak
Nobunao Wakabayashi
Thomas W Kensler
P2860
P304
P356
10.1128/MCB.23.23.8786-8794.2003
P407
P577
2003-12-01T00:00:00Z